{
  "docId": "019de071-b74f-770c-80cd-22f6f746fca1",
  "docSlug": "da6e8db4dad70fc7ff4e589a15b2ab41",
  "documentTitle": "BioNTech | Results Presentation Deck | 40 slides",
  "authorId": "biontech",
  "authorName": "BioNTech",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2021-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 36,
  "pageCount": 40,
  "prevPage": 35,
  "nextPage": 37,
  "slideType": "other",
  "function": "illustrate_case",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": "The slide uses a list-based structure to explain the acquisition of PhagoMed by BioNTech.",
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de071-b74f-770c-80cd-22f6f746fca1/36",
  "deckHref": "/decks/019de071-b74f-770c-80cd-22f6f746fca1",
  "deckJsonHref": "/decks/019de071-b74f-770c-80cd-22f6f746fca1.json",
  "deckAnchorHref": "/decks/019de071-b74f-770c-80cd-22f6f746fca1#slide-36",
  "components": [
    {
      "bbox": {
        "h": 0.65,
        "w": 0.1,
        "x": 0.04,
        "y": 0.18
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "icon-grid",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9883ad2c-b7e8-48bd-8180-fb52a9b48fb0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.18,
        "w": 0.8,
        "x": 0.15,
        "y": 0.65
      },
      "kind": "list",
      "text": "Total consideration can reach up to ~€150.0 m consisting of upfront consideration of ~€50.0 m (less acquired debt) with the possibility of the selling shareholders earning up to an additional ~€100.0 m; Transaction closed in Q3; Forms BioNTech's new R&D hub for precision antibacterials operating as BioNTech R&D Austria",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "32b326b9-0932-4368-997c-c098de05898b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.12,
        "w": 0.8,
        "x": 0.15,
        "y": 0.35
      },
      "kind": "list",
      "text": "Lysins are highly bactericidal phage-derived enzymes that cleave the bacterial cell wall; Potential to address difficult to target pathogens & global challenge of antimicrobial resistance",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7aaa3613-821c-4ced-8181-7095794a643f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.8,
        "x": 0.15,
        "y": 0.5
      },
      "kind": "list",
      "text": "LysinBuilder in silico technology platform based on proprietary algorithms; Designed to rapidly produce recombinant natural lysins against a wide range of pathogens; Optimization for potency, stability and manufacturing yield",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "eb1b5a1a-da76-4f73-a181-1ac820a25baa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.8,
        "x": 0.15,
        "y": 0.2
      },
      "kind": "list",
      "text": "PhagoMed: based in Vienna, Austria; Pioneering new class of precision antibacterials called synthetic lysins",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ec3604b2-20e9-420e-ad28-c700607b0de0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.92,
        "x": 0.04,
        "y": 0.85
      },
      "kind": "subtitle",
      "text": "Acquisition expands Infectious Disease Toolkit: mRNA Vaccines | mRNA Encoded Antibodies | Precision Anti-bacterials",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "641d4b74-4add-4d10-b836-4b58cc1eeedd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.92,
        "x": 0.04,
        "y": 0.08
      },
      "kind": "title",
      "text": "Expansion into New Class of Precision Antibacterials with PhagoMed Acquisition",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3d34b5aa-f195-4836-a1ac-617d8a58d33f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "5525d8cd-170f-4a07-bf09-1440ca0f0c87",
      "evidence": "Expansion into New Class of Precision Antibacterials with PhagoMed Acquisition",
      "confidence": 0.7
    },
    {
      "name": "List presentation",
      "slug": "list-presentation",
      "agent": null,
      "layer": "slide",
      "matchId": "8b051f1a-7d77-49cb-9245-75d71a681933",
      "evidence": "list/bullet: Total consideration can reach up to ~€150.0 m consisting of upfront consideration of ~€50.0 m (less acquired debt) with the possibility of the selling shareholders earning up to an additional ~€100.0 m; Tran",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 40,
      "from": 21,
      "beatId": "86ee922b-3b38-407a-91d0-e5fba14e6389",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Action",
      "beatSlug": "monroes-sequence-action",
      "evidence": "The presentation concludes with financial results, outlook, and future plans",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}